Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.77 USD | +2.31% | +2.17% | -41.28% |
May. 10 | Ocuphire Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 11 | Ocuphire Pharma Enrolls 1st Patient in Phase 3 Trial of Visual Acuity Treatment | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-41.28% | 44.3M | |
+37.31% | 723B | |
+31.31% | 598B | |
-2.91% | 364B | |
+20.41% | 331B | |
+4.10% | 288B | |
+16.15% | 244B | |
+9.83% | 210B | |
-5.03% | 208B | |
+8.85% | 169B |
- Stock Market
- Equities
- OCUP Stock
- News Ocuphire Pharma, Inc.
- Ocuphire Pharma Appoints George Magrath as Chief Executive